Balyasny Asset Management’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.59M | Sell |
18,707
-2,976,512
| -99% | -$265M | ﹤0.01% | 1889 |
|
|
2025
Q4 | $237M | Buy |
+2,995,219
| New | +$235M | 0.3% | 45 |
|
|
2025
Q3 | – | Sell |
-1,193,435
| Closed | -$108M | – | 2972 |
|
|
2025
Q2 | $108M | Buy |
1,193,435
+1,191,094
| +50,880% | +$109M | 0.16% | 136 |
|
|
2025
Q1 | $219K | Buy |
+2,341
| New | +$210K | ﹤0.01% | 2552 |
|
|
2024
Q3 | – | Sell |
-772,808
| Closed | -$75M | – | 2783 |
|
|
2024
Q2 | $75M | Buy |
772,808
+466,234
| +152% | +$43M | 0.13% | 188 |
|
|
2024
Q1 | $27.6M | Buy |
306,574
+6,519
| +2% | +$552K | 0.05% | 498 |
|
|
2023
Q4 | $23.9M | Buy |
+300,055
| New | +$22.6M | 0.04% | 535 |
|
|
2023
Q3 | – | Sell |
-1,649,592
| Closed | -$127M | – | 2304 |
|
|
2023
Q2 | $127M | Buy |
1,649,592
+1,626,827
| +7,146% | +$126M | 0.28% | 67 |
|
|
2023
Q1 | $1.71M | Sell |
22,765
-1,258,469
| -98% | -$93.6M | ﹤0.01% | 1517 |
|
|
2022
Q4 | $101M | Buy |
1,281,234
+1,217,955
| +1,925% | +$91.3M | 0.28% | 72 |
|
|
2022
Q3 | $4.45M | Sell |
63,279
-376,497
| -86% | -$29.5M | 0.01% | 1065 |
|
|
2022
Q2 | $35.2M | Buy |
+439,776
| New | +$34.4M | 0.11% | 249 |
|
|
2021
Q4 | – | Sell |
-1,278,155
| Closed | -$96.6M | – | 2282 |
|
|
2021
Q3 | $96.6M | Buy |
+1,278,155
| New | +$101M | 0.4% | 29 |
|
|
2020
Q1 | – | Sell |
-809,217
| Closed | -$55.7M | – | 1200 |
|
|
2019
Q4 | $55.7M | Buy |
809,217
+438,703
| +118% | +$29.9M | 0.33% | 71 |
|
|
2019
Q3 | $27.2M | Buy |
+370,514
| New | +$26.9M | 0.19% | 162 |
|
|
2018
Q4 | – | Sell |
-20,182
| Closed | -$1.35M | – | 1442 |
|
|
2018
Q3 | $1.35M | Sell |
20,182
-44,770
| -69% | -$2.98M | 0.01% | 1094 |
|
|
2018
Q2 | $4.21M | Buy |
+64,952
| New | +$4.25M | 0.02% | 717 |
|
|
2018
Q1 | – | Sell |
-273,946
| Closed | -$20.7M | – | 1979 |
|
|
2017
Q4 | $20.7M | Buy |
273,946
+270,787
| +8,572% | +$19.8M | 0.06% | 395 |
|
|
2017
Q3 | $230K | Sell |
3,159
-264,143
| -99% | -$19M | ﹤0.01% | 1647 |
|
|
2017
Q2 | $19.8M | Sell |
267,302
-92,396
| -26% | -$6.86M | 0.08% | 316 |
|
|
2017
Q1 | $26.3M | Buy |
359,698
+327,485
| +1,017% | +$22.9M | 0.12% | 219 |
|
|
2016
Q4 | $2.11M | Sell |
32,213
-1,062,849
| -97% | -$72.9M | 0.01% | 872 |
|
|
2016
Q3 | $81.2M | Sell |
1,095,062
-192,473
| -15% | -$14.2M | 0.47% | 45 |
|
|
2016
Q2 | $94.2M | Buy |
1,287,535
+650,152
| +102% | +$46.3M | 0.61% | 16 |
|
|
2016
Q1 | $45M | Buy |
+637,383
| New | +$42.4M | 0.27% | 101 |
|
|
2015
Q4 | – | Sell |
-8,468
| Closed | -$537K | – | 1256 |
|
|
2015
Q3 | $537K | Sell |
8,468
-362,432
| -98% | -$23.7M | ﹤0.01% | 812 |
|
|
2015
Q2 | $24.3M | Buy |
+370,900
| New | +$25.2M | 0.15% | 176 |
|
|
2014
Q2 | – | Sell |
-298,908
| Closed | -$19.4M | – | 646 |
|
|
2014
Q1 | $19.4M | Buy |
+298,908
| New | +$18.8M | 0.22% | 127 |
|
|
2013
Q4 | – | Sell |
-368,951
| Closed | -$21.9M | – | 508 |
|
|
2013
Q3 | $21.9M | Buy |
+368,951
| New | +$21.9M | 0.3% | 87 |
|
Other funds holding CL
VCM
DAM
VPM
Balyasny Asset Management's CL Position: Q1 2026 in Review
Balyasny Asset Management reduced its Colgate-Palmolive (CL) stake by 99% in Q1 2026, selling an estimated $265M and leaving 18,707 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1889.
Balyasny Asset Management first reported a position in CL in Q3 2013 and has held it in 29 quarters since. The position peaked at $237M in Q4 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Balyasny Asset Management held 18,707 shares of Colgate-Palmolive worth $1.59M as of Q1 2026.
- Balyasny Asset Management sold 2,976,512 Colgate-Palmolive shares in Q1 2026, an estimated $265M.
- Colgate-Palmolive made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1889 holding.
- Balyasny Asset Management first reported a position in Colgate-Palmolive in Q3 2013 and has held it in 29 quarters since.
- Balyasny Asset Management's Colgate-Palmolive position peaked at $237M in Q4 2025.
- 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.